Projects per year
Fingerprint
Dive into the research topics where Shannon McWeeney is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Understanding the origins of rapid recurrence of pancreatic cancer after resection
Bergan, R., Coussens, L., McWeeney, S., Spellman, P., Streeter, P., Winters-Stone, K., Bagby, G., Mori, M., Corless, C., Harrington, C., Hoatlin, M., Koop, D., Magun, B., Druker, B., Shannon, J. & Kummar, S.
Project: Research project
-
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation
Nelson, J., Caposio, P., McWeeney, S., Streblow, D., Caposio, P., Nelson, J., Caposio, P., McWeeney, S. & Streblow, D.
Project: Research project
-
Pacific NorthWest Regional Center of Excellence (PNWRCE)
Axthelm, M., Barklis, E., Frueh, K., McWeeney, S., Moses, A., Nelson, J., Slifka, M. & Streblow, D.
Project: Research project
-
OHSU Informatics Analytics BD2K Skill Course
Dorr, D., Haendel, M. & McWeeney, S.
Project: Research project
-
-
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia
Barnes, E. J., Eide, C. A., Kaempf, A., Bottomly, D., Romine, K. A., Wilmot, B., Saunders, D., McWeeney, S. K., Tognon, C. E. & Druker, B. J., Feb 2023, In: British Journal of Haematology. 200, 3, p. 323-328 6 p.Research output: Contribution to journal › Article › peer-review
-
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Damnernsawad, A., Bottomly, D., Kurtz, S. E., Eide, C. A., McWeeney, S. K., Tyner, J. W. & Nechiporuk, T., Jan 2022, In: Haematologica. 107, 1, p. 77-85 9 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
Kurtz, S. E., Eide, C. A., Kaempf, A., Long, N., Bottomly, D., Nikolova, O., Druker, B. J., McWeeney, S. K., Chang, B. H., Tyner, J. W. & Agarwal, A., May 24 2022, In: Blood Advances. 6, 10, p. 3062-3067 6 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5455), 10.1038/s41467-019-13364-2)
Braun, T. P., Okhovat, M., Coblentz, C., Carratt, S. A., Foley, A., Schonrock, Z., Curtiss, B. M., Nevonen, K., Davis, B., Garcia, B., LaTocha, D., Weeder, B. R., Grzadkowski, M. R., Estabrook, J. C., Manning, H. G., Watanabe-Smith, K., Jeng, S., Smith, J. L., Leonti, A. R., Ries, R. E., & 8 others, Dec 2022, In: Nature communications. 13, 1, 3471.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Biology and medicine in the landscape of quantum advantages
Cordier, B. A., Sawaya, N. P. D., Guerreschi, G. G. & Mcweeney, S. K., Nov 30 2022, In: Journal of the Royal Society Interface. 19, 196, 20220541.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations